Últimas publicaciones
The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Tiberio P, Antunovic L, Gaudio M, Viganò A, Pastore M, Miggiano C, Jacobs F, Benvenuti C, Farina E, Chiti A, Santoro A, De Sanctis R.
Blood pool phase SPECT: the missing link of bone scintigraphy
Morland D, Antunovic L.
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis
Online ahead of print. Antunovic L, Artesani A, Coniglio M, Oyen WJG, Ciccarelli M, Selmi C, Chiti A, Sollini M.
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas
Ninatti G, Sollini M, Bono B, Gozzi N, Fedorov D, Antunovic L, Gelardi F, Navarria P, Politi LS, Pessina F, Chiti A.
EANM Bone & Joint Committee, the Dosimetry Committee, the Oncology & Theranostics Committee.The EANM guideline for radiosynoviorthesis
Kampen WU, Boddenberg-Pätzold B, Fischer M, Gabriel M, Klett R, Konijnenberg M, Kresnik E, Lellouche H, Paycha F, Terslev L, Turkmen C, van der Zant F, Antunovic L, Panagiotidis E, Gnanasegaran G, Kuwert T, Van den Wyngaert T;
PET/CT radiomics in breast cancer: Mind the step
Sollini M, Cozzi L, Ninatti G, Antunovic L, Cavinato L, Chiti A, Kirienko M.
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome
Sollini M, di Tommaso L, Kirienko M, Piombo C, Erreni M, Lania AG, Erba PA, Antunovic L, Chiti A.
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics
Sollini M, Antunovic L, Chiti A, Kirienko M.
[18F]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria
Sollini M, Trenti N, Malagoli E, Catalano M, Di Mento L, Kirienko A, Berlusconi M, Chiti A, Antunovic L.
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy
Antunovic L, De Sanctis R, Cozzi L, Kirienko M, Sagona A, Torrisi R, Tinterri C, Santoro A, Chiti A, Zelic R, Sollini M.
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT
Kirienko M, Sollini M, Silvestri G, Mognetti S, Voulaz E, Antunovic L, Rossi A, Antiga L, Chiti A.
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions
Kirienko M, Cozzi L, ; Rossi A, Voulaz E, Antunovic L, Fogliata A, Chiti A, Sollini M.
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis
Ghedini P, Bossert I, Zanoni L, Ceci F, Graziani T, Castellucci P, Ambrosini V, Massari F, Nobili E, Melotti B, Musto A, Zoboli S, Antunovic L, Kirienko M, Chiti A, Mosconi C, Ardizzoni A, Golfieri R, Fanti S, Nanni C.
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery
Eur J Nucl Med Mol Imaging. 2017 Sep 24. doi: 10.1007/s00259-017-3837-7.
Kirienko M, Cozzi L, Antunovic L, Lozza L, Fogliata A, Voulaz E, Rossi A, Chiti A, Sollini M.
[18F]FDG PET/CT features for the molecular characterisation of primary breast tumours
Eur J Nucl Med Mol Imaging. 2017;44:1945-1954. (DOI 10.1007/s00259-017-3770-9).
Antunovic L, Gallivanone F, Sollini M, Sagona A, Manfrinato G, Invento A, Kirienko M, Tinterri C, Chiti A, Castiglioni I.
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology
Sci Rep. 2017;23;7:358. (DOI: 10.1038/s41598-017-00426-y)
Sollini M, Cozzi L, Antunovic L, Chiti A, Kirienko M.
